The Bench Report

The Parky Charter: Improving Care and Funding for Parkinson's Disease

The Bench Report Season 5 Episode 6

As one of the fastest growing neurological conditions, affecting over 116,000 people in the UK, patients face challenges like long waits for specialist appointments and fragmented care. The debate focused on implementing the Parky charter, a powerful five-point plan demanding speedy access to specialists, coordinated support through a Parkinson’s passport, and renewed investment in finding a cure. We examine the crucial link between timely care, consistent medication access, and ensuring dignity for all sufferers.

Key Takeaways

  • The e-petition supporting the Parky charter garnered over 113,000 signatures, demonstrating a collective call for meaningful action to improve care.
  • Parkinson’s is a fast-growing neurological condition, with the number of people affected in the UK expected to reach 173,000 by 2030.
  • Patients often struggle with access to specialist services; the UK ranks near the bottom in Europe for the number of neurologists per capita, and only about half of neurology services meet the 18-week referral target.
  • Receiving medication is time-critical; delays of just 30 minutes in a hospital can severely worsen symptoms, yet more than half of hospitalised patients report such delays.
  • The Personal Independence Payment (PIP) assessment system frequently fails to capture the complexity and fluctuating nature of Parkinson's, leading to inaccurate assessments.
  • A holistic approach to care is essential, combining specialist medical support with community initiatives such as walking football and physical activity courses.

Definitions 

  • Parky Charter: A five-point manifesto created by the "Movers and Shakers" podcast group, calling for reform in care, including immediate information, specialist access, support coordination via a Parkinson’s passport, comprehensive care, and research investment.

Source: Parkinson’s Disease
Volume 775: debated on Monday 17 November 2025

Follow and subscribe to 'The Bench Report' on Apple, Spotify, and YouTube for new episodes daily: thebenchreport.co.uk

Subscribe to our Substack

Shape our next episode! Get in touch with an issue important to you - Producer Tom will grab another coffee and start the research!

Email us: thebenchreportuk@gmail.com

Follow us on YouTube, X, Bluesky, Facebook, Instagram and TikTok! @benchreportUK

Support us for bonus and extended episodes + more.

No outside chatter: source material only taken from Hansard and the Parliament UK website.

Contains Parliamentary information repurposed under the Open Parliament Licence v3.0...

Ivan:

Hello and welcome once more to the Bench Report, where we discuss recent debates from the benches of the UK Parliament, a new topic every episode. You're listening to Amy and Ivan. Today we are looking at the conversation spurred by ePetition 713714. It drew over 113,000 signatures, all demanding better funding and support for people living with Parkinson's. Let's start with the scale of this. Parkinson's is, well, it's one of the fastest growing neurological conditions in the world. The numbers that came up are quite stark. Over 116,000 people are currently affected in the UK, and that's expected to jump to 173,000 by 2030.

Amy:

And you have to understand the cost behind that number. It goes so far beyond just the clinical side of things. This condition can plunge families into a financial crisis almost immediately. If you include lost earnings, the average cost to a household is nearly 22,000 pounds every single year. Even without that, just managing the condition is over 70,500 pounds.

Ivan:

That real-world cost really brings us to the core proposal that was discussed, which is the Parkey Charter. It's a five-point plan for change put together by the Movers and Shakers group. The demands are faster specialist access, clear info right after diagnosis, a Parkinson's passport, comprehensive support, and of course, renewed funding for research. That idea of a Parkinson's passport that really stood out. Why is a tool like that so important?

Amy:

Well, to see why the passport is so critical, you have to look at the huge problem underneath it all, the specialist shortage. I mean, that the UK ranks near the bottom in Europe for the number of neurologists per person. And that shortage directly leads to these enormous delays. Right now, only about half of neurology services are even meeting the 18-week referral target. I think there's something like 21,000 people out there living with Parkinson's completely undiagnosed.

Ivan:

So if that basic access to a specialist is broken, how does that ripple outwards into day-to-day patient care? Because these are time critical needs we're talking about. Medication timing is everything. Treatment has to be given within 30 minutes of the prescribed time, or things can go downhill fast. How can it be that more than half of patients in hospital, the one place they should be safe, report these kinds of delays?

Amy:

And that delay isn't just a failure in care, it's a massive financial drain on the NHS. The system is spending 325 million TAWs a year on unplanned hospital admissions for people with Parkinson's, many of which are caused by those very same preventable medication delays. It also brings up big questions about our benefit system. The personal independence payment or PIP assessments often just fail. They can't capture the condition's fluctuating nature.

Ivan:

Can you just explain that fluctuating nature because it feels absolutely central to the whole problem with support?

Amy:

Of course. Imagine you're being tested on something, but your ability to walk or to speak changes every 20 minutes. The standard benefit assessment is just a single snapshot in time. It might catch you on a so-called good half hour and completely miss the severe reality of your condition an hour later. And that's why the passport is so vital. It helps everyone, from nurses to benefit staff, see the whole picture, not just that one snapshot. The government is working with Parkinson's UK on this, but a full review isn't expected until autumn 2026.

Ivan:

It's not all bleak, though. There are some really positive, holistic things happening. Community programs like walking football and even judo classes were mentioned. And on the medical front, there are innovations like Proto-Dopa, which was approved in 2024. It's a wearable pump that delivers a continuous dose of medication for those with severe symptoms.

Amy:

And that brings the whole argument back to consistency. We have these brilliant treatments and amazing local support groups, but access can't be a postcode lottery. The goal has to be consistency across all four UK regions, so that everyone has the same fair access to specialists and innovative care.

Ivan:

That's our analysis for today. Here is the final thought for you to chew on. If we know the proactive specialist-led care is substantially cheaper than reacting to crises, saving the NHS hundreds of millions in unplanned hospital admissions, why is the necessary infrastructure investment still lagging? As always, find us on social media at BenchReport UK. Get in touch with any topic important to you. Remember, politics is everyone's business. Take care.

Podcasts we love

Check out these other fine podcasts recommended by us, not an algorithm.